These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 23678366)

  • 21. Effects of prostratin on Cyclin T1/P-TEFb function and the gene expression profile in primary resting CD4+ T cells.
    Sung TL; Rice AP
    Retrovirology; 2006 Oct; 3():66. PubMed ID: 17014716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dephosphorylation of CDK9 by protein phosphatase 2A and protein phosphatase-1 in Tat-activated HIV-1 transcription.
    Ammosova T; Washington K; Debebe Z; Brady J; Nekhai S
    Retrovirology; 2005 Jul; 2():47. PubMed ID: 16048649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 Tat phosphorylation on Ser-16 residue modulates HIV-1 transcription.
    Ivanov A; Lin X; Ammosova T; Ilatovskiy AV; Kumari N; Lassiter H; Afangbedji N; Niu X; Petukhov MG; Nekhai S
    Retrovirology; 2018 May; 15(1):39. PubMed ID: 29792216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 Tat interaction with RNA polymerase II C-terminal domain (CTD) and a dynamic association with CDK2 induce CTD phosphorylation and transcription from HIV-1 promoter.
    Deng L; Ammosova T; Pumfery A; Kashanchi F; Nekhai S
    J Biol Chem; 2002 Sep; 277(37):33922-9. PubMed ID: 12114499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphatase PPM1A negatively regulates P-TEFb function in resting CD4(+) T cells and inhibits HIV-1 gene expression.
    Budhiraja S; Ramakrishnan R; Rice AP
    Retrovirology; 2012 Jun; 9():52. PubMed ID: 22727189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter.
    Fong YW; Zhou Q
    Mol Cell Biol; 2000 Aug; 20(16):5897-907. PubMed ID: 10913173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CDK9: from basal transcription to cancer and AIDS.
    De Falco G; Giordano A
    Cancer Biol Ther; 2002; 1(4):342-7. PubMed ID: 12432243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of TAK/P-TEFb in CD4+ T lymphocytes and macrophages.
    Rice AP; Herrmann CH
    Curr HIV Res; 2003 Oct; 1(4):395-404. PubMed ID: 15049426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional interaction between cyclin T1/cdk9 and Puralpha determines the level of TNFalpha promoter activation by Tat in glial cells.
    Darbinian N; Sawaya BE; Khalili K; Jaffe N; Wortman B; Giordano A; Amini S
    J Neuroimmunol; 2001 Dec; 121(1-2):3-11. PubMed ID: 11730934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation.
    Ivanov D; Kwak YT; Nee E; Guo J; García-Martínez LF; Gaynor RB
    J Mol Biol; 1999 Apr; 288(1):41-56. PubMed ID: 10329125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The CDK9-associated cyclins T1 and T2 exert opposite effects on HIV-1 Tat activity.
    Napolitano G; Licciardo P; Gallo P; Majello B; Giordano A; Lania L
    AIDS; 1999 Aug; 13(12):1453-9. PubMed ID: 10465067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 infection and regulation of Tat function in macrophages.
    Liou LY; Herrmann CH; Rice AP
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1767-75. PubMed ID: 15183343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.
    Agbottah E; Deng L; Dannenberg LO; Pumfery A; Kashanchi F
    Retrovirology; 2006 Aug; 3():48. PubMed ID: 16893449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CDK9 a potential target for drug development.
    Canduri F; Perez PC; Caceres RA; de Azevedo WF
    Med Chem; 2008 May; 4(3):210-8. PubMed ID: 18473913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of a protein phosphatase 1 inhibitor, cdNIPP1, increases CDK9 threonine 186 phosphorylation and inhibits HIV-1 transcription.
    Ammosova T; Yedavalli VR; Niu X; Jerebtsova M; Van Eynde A; Beullens M; Bollen M; Jeang KT; Nekhai S
    J Biol Chem; 2011 Feb; 286(5):3798-804. PubMed ID: 21098020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of CDKs in RNA polymerase II transcription of the HIV-1 genome.
    Rice AP
    Transcription; 2019 Apr; 10(2):111-117. PubMed ID: 30375919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression.
    Fujinaga K; Irwin D; Geyer M; Peterlin BM
    J Virol; 2002 Nov; 76(21):10873-81. PubMed ID: 12368330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 replication and latency are regulated by translational control of cyclin T1.
    Hoque M; Shamanna RA; Guan D; Pe'ery T; Mathews MB
    J Mol Biol; 2011 Jul; 410(5):917-32. PubMed ID: 21763496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of HIV-1 transcription and replication by a newly identified cyclin T1 splice variant.
    Gao G; Wu X; Zhou J; He M; He JJ; Guo D
    J Biol Chem; 2013 May; 288(20):14297-14309. PubMed ID: 23569210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of Tat in HIV-1 replication: an activator and/or a suppressor?
    Liang C; Wainberg MA
    AIDS Rev; 2002; 4(1):41-9. PubMed ID: 11998784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.